Madrigal Pharmaceuticals provided an update on its financial performance, revealing preliminary fourth-quarter and full-year 2024 net sales for Rezdiffra™ (resmetirom) projected between $100 million ...
CHARLOTTE, N.C.--(BUSINESS WIRE)--Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (Nasdaq: BHF) announced today its financial results for the fourth quarter and full year ended ...
LOUISVILLE, Ky.--(BUSINESS WIRE)--Republic Bancorp, Inc. (“Republic” or the “Company”) reported fourth quarter 2024 net income and Diluted Earnings per Class A Common Share (“Diluted EPS”) of $19.0 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果